Amgen: Investments against COVID-19 Foreign Investors
Entity: Amgen
Category: Foreign Investors
Description: Amgen is one of the world’s leading biotechnology companies. This company is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. They offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
+ Investing in:
. Oxford Nanopore Technologies
Category: Foreign Investors
Description: Amgen is one of the world’s leading biotechnology companies. This company is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses. They offers products for the treatment of illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.
+ Investing in:
. Oxford Nanopore Technologies
Technology:
COVID UK Funding&Support
Industry:
COVID UK Non-governmental Bodies
Headquarters:
United States
Founded Date:
N/A
Employees Number:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A
Number Of Exits:
N/A
Register and Claim Ownership